You are here: Industry Insights > Antibiotic

News List

AstraZeneca spinout Entasis files for $86M IPO to fund antibiotic phase 3 fiercebiotech
August 21, 2018
Entasis Therapeutics has filed to raise up to $86 million through an IPO. The AstraZeneca spinout is seeking the money to fund a phase 3 trial of a drug to overcome bacterial resistance to beta-lactams.
Achaogen wields ax on R&D, C-suite as antibiotic launch gets underway fiercepharma
July 30, 2018
The impact of Achaogen’s narrower-than-expected label for antibiotic Zemdri is now apparent: The biotech has slashed 28% of its staff and all but two R&D programs.
Antibiotic supply chains on 'brink of collapse' pharmatimes
July 06, 2018
The Access to Medicine Foundation has warned that antibiotic supply chains are on the brink of collapse, putting basic healthcare at risk.
Nabriva closes in on bringing new class of antibiotic to market pharmafile
May 25, 2018
Nabriva Therapeutics, a biotech based in Dublin, Ireland, has announced positive Phase 3 data for its antibiotic, lefamulin, which could result in a newly approved antibiotic for doctors to utilise – a type of approval that are few and far between.
Rapid Detection of Pathogen and Antibiotic Resistance with DNAe’s LiDia® Bloodstream Infection (BSI) Technology b3cnewswire
April 26, 2018
DNAe, announces new data generated with its LiDia® Bloodstream Infection (BSI) technology, currently in development.
Rapid Detection of Pathogen and Antibiotic Resistance with DNAe’s LiDia® Bloodstream Infection (BSI) Technology b3cnewswire
April 25, 2018
DNAe announces new data generated with its LiDia® Bloodstream Infection (BSI) technology, currently in development.
Iterum Therapeutics Presents Data on Prevalence of Resistant Infections and Activity of its Novel Antibiotic Sulopenem biospace
April 23, 2018
Iterum Therapeutics plc, will deliver a mini-oral presentation and two additional posters at the European Congress of Clinical Microbiology in Madrid, Spain from April 21 to 24, 2018.
Test for antibiotic associated kidney damage in children with CF identified europeanpharmaceuticalreview
April 02, 2018
New research highlights effective methods for identifying a common side effect in children receiving drug treatments for Cystic fibrosis…
Allecra Therapeutics New Antibiotic Shows Promise for Resistant Bacterial Infections biospace
March 27, 2018
Based in Lorrach, Germany and Saint Louis, France, Allecra Therapeutics releasedpositive top-line data from its Phase II trial of AAI101, an antibiotic against gram-negative bacteria.
Scientists develop rapid test that determines antibiotic resistance europeanpharmaceuticalreview
March 20, 2018
Scientists in Germany have developed a test using electric fields and Raman spectroscopy to ascertain specific antibiotic resistance of pathogens and thus enable the prescription of effective treatment.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page